Johnson & Johnson Vision Launches TECNIS Toric II 1-Piece IOL as a New Monofocal Option for Cataract Patients with Astigmatism in the US
Shots:
- J&J Vision reports the US FDA approval and launch of two post-market clinical trials to demonstrate the rotational stability and visual outcomes offered by the TECNIS Toric II platform, conducted at 50 sites across the US in 1000 patients
- The focus of the launch is to provide surgeons with a higher degree of confidence in treating astigmatism and to raise the standard of care for patients with cataracts
- TECNIS Toric II 1-Piece Intraocular Lens is the first IOL offered on the new TECNIS Toric II platform, featuring more surface texture and friction on the IOL haptics
Click here to read full press release/ article | Ref: JNJ | Image: PRNewswire